Potentiation of oncogenic N-ras-induced neurite outgrowth and ornithine decarboxylase activity by phorbol dibutyrate and protein kinase inhibitor H-8

J Cell Physiol. 1990 Apr;143(1):68-78. doi: 10.1002/jcp.1041430109.

Abstract

A recombinant N-ras oncogene, under the transcriptional control of a corticosteroid-inducible mouse mammary tumor virus (MMTV) promoter, has been stably transfected into a PC12 rat pheochromocytoma subline. This cell line, designated UR61, undergoes N-ras-induced neurite outgrowth and cessation of division when treated with dexamethasone (Guerrero et al.: Biochemical and Biophysical Research Communications 150:1185-1192, 1988). We have employed the UR61 cell line as a model for ras oncogene-induced neuronal differentiation. In UR61 cells, dexamethasone-induced expression of the recombinant N-ras gene resulted in time-dependent expression of ornithine decarboxylase enzyme (ODC) activity. Prompted by recent reports of possible functional (Lacal et al.: Molecular and Cellular Biology 7:4146-4149, 1987; Wolfman and Macara: Nature 325: 359-361, 1987) and direct (Jeng et al.: Biochemical and Biophysical Research Communications 145:782-788, 1987) interactions between oncogene ras-coded p21 and protein kinase C (PK-C; Ca++/phospholipid-dependent protein kinase), we employed the protein kinase inhibitor H-8 (N-[2-(methylamino)ethyl]-5-isoquinoline sulfonamide dihydrochloride) and phorbol 12,13-dibutyrate (PDBu) to investigate this putative interaction in the UR61 cells, where ODC activity and neurite outgrowth were used as indicators of oncogenic N-ras action. Treatment of UR61 cells with PDBu depleted cells of PK-C and failed to promote neurite outgrowth but enhanced N-ras-induced neurite outgrowth and ODC activity. H-8, which suppressed ODC induction by forskolin and phorbol myristate acetate, enhanced both N-ras-induced ODC activity and neurite outgrowth. Inhibition of ODC activity by difluoromethylornithine (DFMO) did not suppress oncogenic ras-induced neurite outgrowth, suggesting that these two ras-triggered events are mechanistically independent. These findings suggest that certain actions of N-ras can occur in cells depleted of PK-C, and thus, the role of PK-C in ras-induced differentiation differs from its role in ras-induced mitogenesis and transformation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cell Differentiation / drug effects
  • Cell Transformation, Neoplastic
  • Colforsin / pharmacology
  • Dexamethasone / pharmacology
  • Epidermal Growth Factor / pharmacology
  • Isoquinolines / pharmacology*
  • Nerve Growth Factors / pharmacology
  • Neurons / cytology*
  • Oncogene Protein p21(ras) / physiology*
  • Ornithine Decarboxylase / metabolism*
  • Phorbol 12,13-Dibutyrate / pharmacology*
  • Protein Kinase C / physiology
  • Protein Kinase Inhibitors*
  • Rats
  • Tetradecanoylphorbol Acetate / pharmacology
  • Tretinoin / pharmacology
  • Tumor Cells, Cultured

Substances

  • Isoquinolines
  • Nerve Growth Factors
  • Protein Kinase Inhibitors
  • Colforsin
  • Phorbol 12,13-Dibutyrate
  • Tretinoin
  • Epidermal Growth Factor
  • Dexamethasone
  • N-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide
  • Protein Kinase C
  • Oncogene Protein p21(ras)
  • Ornithine Decarboxylase
  • Tetradecanoylphorbol Acetate